CVS Health Corporation (NYSE:CVS) awarded more than $10 million in 2019 to support youth smoking and e-cigarette prevention strategies
Given the significant increase in the number of teens using e-cigarettes, CVS Health Corporation (NYSE:CVS) announced that it and its charitable foundations will award a total of more than $10 million in 2019 to support youth smoking and e-cigarette prevention strategies and education delivered in classrooms, by clinicians and in communities across the United States. The new commitment, funded through the company and the CVS Health and Aetna Foundations, is part of Be The First, CVS Health’s five-year $50 million initiative to help deliver the nation’s first tobacco-free generation.
Technical Stock Analysis
CVS Health Corporation (NYSE:CVS), a Healthcare sector firm, traded 12.49 Million shares in last trading session and stock slipped -0.41% with closing price of $53.65 per share. Company gross margins represents its total sales revenue minus its cost of goods sold (COGS), divided by the total sales revenue earned by the company, expressed as a percentage. And its good to know that the higher that percentage, the more the company retains on each dollar of sales, to service its other costs and the debt obligations, and CVS Health Corporation (NYSE:CVS)’s gross margin stands at 26.40%.
Investment Worthy Stock or not?
For personal guess ROI is usually expressed as a percentage and is typically used for taking any financial decisions, for the purpose of comparing a CVS Health Corporation (NYSE:CVS)’s profitability or to compare the efficiency of different investments, hence, CVS return on investment (ROI) is 1.50%.
52-Week Range are valuable stats for watching CVS Health Corporation (NYSE:CVS)’s past year fluctuation as that gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range. CVS Health Corporation (NYSE:CVS)’s stock value has moved between $51.59 – 82.54 in last one year.
Analysts mean target price for CVS Health Corporation (NYSE:CVS) is $68.65 while analysts mean recommendation is 2.10.
Its weekly performance is -0.96% while year to date (YTD) performance is -18.12%.
Earnings per share growth is defined as the percentage change in normalised earnings per share over the previous 12 month period to the latest year end. It gives a good picture of the rate at which a company has grown its profitability. CVS Health Corporation (NYSE:CVS)’s EPS growth this year is -113.40%. For best decision making investors should look at CVS Health Corporation (NYSE:CVS)’s EPS growth for next year stands at 4.41%.